TTS PHARMA LIMITED APPOINTS ROBIN EMERSON TO EXECUTIVE MANAGEMENT TEAM
- Founder of Jorja Botanicals appointed to the Executive Management Team of TTS Pharma
- Robin Emerson has joined the Company’s Leadership team as Director of Business Development and Regulatory Affairs.
- Robin Emerson is CEO of Jorja Botanicals and is a leading advocate for the expansion of medical cannabis in the UK. Robin’s campaigning was inspired by his experience with his own daughter, Jorja, whose intractable epilepsy has been successfully treated by medicinal cannabis for the past 3 years.
TTS Pharma has made the appointment to enable the business to expand its offer to clients and forge stronger partnerships across the industry. Robin is also responsible for regulatory affairs including discussions with the Food Standards Agency (“FSA”).
Robin Emerson believes his appointment will help the Company to continue to expand and stated “I am delighted to join the team at TTS Pharma having worked with them as a client for their products over recent years. I have consistently been impressed by the Company’s commitment to create a diverse range of legal and compliant products of the highest standards and to meet the new regulatory requirements being set by the FSA.”
“My other leadership positions at Elite Growth and Jorja Botanicals will enable the offering at TTS Pharma to rapidly expand into new areas.”
“I strongly support the drive by the FSA to ensure that all CBD products on the market meet the highest standards and to prevent rogue providers from operating in the UK. Those standards are vital to ensuring that consumers can feel confident that the products they purchase pose no risk to their health.”
TTS Pharma CEO, Mark Tucker commented “We are delighted to have Robin join the TTS Pharma team. He has already had a significant impact in using his experience as a father to show how medicinal cannabis can help those with particular health conditions. We believe Robin can make a difference in helping the business expand its profile further whilst upholding our high regulatory standards”
About TTS Pharma
TTS Pharma is a private company, incorporated in England and Wales established in 2012, with offices in Liverpool. The Company holds deep industry expertise in extraction and separation of Phytoactive API ingredients and converting into finished product formats using sustained release formats. As UK’s first EFSA CBD Novel Food applicant in 2019 and having filed a number of dossiers with the UK’s FSA, the Company supplies a growing number of CBD brands in UK, with exports to Germany, Portugal and South Africa. The Company sponsors a number of R&D projects at several leading UK Universities under Home Office Licenses and respects all existing legal and regulatory requirements in the UK. TTS Pharma is committed to a compliant and legal CBD supply chain and is one of the few companies to have this recognised by Trading Standards through its Primary Authority approval by Hertfordshire Trading Standards. TTS Pharma’s products follow a controlled, fully traceable process that complies with general Food Law (UK) including labelling and promotional materials for safe, repeatable use of CBD containing product.